Latest filing published 17 Dec 2012 for Merrimack Pharmaceuticals INC, €33k.
Insider track record
No signal scores available.
Fazal R. Khan: trading record in brief
Fazal R. Khan discloses dealings in Merrimack Pharmaceuticals Inc to SEC (Form 4). In total, 4 filings cover trades dated from 13 December 2012 to 17 December 2012.
Sales make up the whole of the open-market record (2 sales, €250k). Besides market trades, the filings include 2 option exercises.
On 17 December 2012 came the latest disclosure, an option exercise for €33k in Merrimack Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Fazal R. Khan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$1.71Common StockSEC:0001179110-12-017781:0
- 25,000 shares@ US$6.73Common StockSEC:0001179110-12-017781:1
- 25,000 shares@ US$1.71Common StockSEC:0001179110-12-017781:2
- 25,000 shares@ US$6.41Common StockSEC:0001179110-12-017781:3
4 of 4 declarations
